Botulinum toxin type a induces direct analgesic effects in chronic neuropathic pain

The Hospital Anxiety and Depression Scale

1983 • 42,177 citations

Pain assessment: global use of the Brief Pain Inventory.

1994 • 4,845 citations

Persistent postsurgical pain: risk factors and prevention

2006 • 3,700 citations

Pharmacologic management of neuropathic pain: Evidence-based recommendations

2007 • 2,078 citations

Prevalence of chronic pain with neuropathic characteristics in the general population

2007 • 1,577 citations

Algorithm for neuropathic pain treatment: An evidence based proposal

2005 • 1,341 citations

Development and validation of the Neuropathic Pain Symptom Inventory

2004 • 1,184 citations

The Epidemiology of Chronic Pain of Predominantly Neuropathic Origin. Results From a General Population Survey

2006 • 971 citations

EFNS guidelines on pharmacological treatment of neuropathic pain

2006 • 889 citations

SV2 Is the Protein Receptor for Botulinum Neurotoxin A

2006 • 741 citations

Subcutaneous administration of botulinum toxin A reduces formalin-induced pain

2003 • 652 citations

The impact of neuropathic pain on health-related quality of life

2007 • 557 citations

Intramuscular Injection of Botulinum Toxin for the Treatment of Wrist and Finger Spasticity after a Stroke

2002 • 554 citations

Postherpetic Neuralgia: Irritable Nociceptors and Deafferentation

1998 • 551 citations

Identification of the Major Steps in Botulinum Toxin Action

2004 • 530 citations

Regulation of Calcitonin Gene‐Related Peptide Secretion From Trigeminal Nerve Cells by Botulinum Toxin Type A: Implications for Migraine Therapy

2004 • 528 citations

Review of a Proposed Mechanism for the Antinociceptive Action of Botulinum Toxin Type A

2005 • 517 citations

Botulinum Toxin A for Axillary Hyperhidrosis (Excessive Sweating)

2001 • 450 citations

Regulated Exocytosis Contributes to Protein Kinase C Potentiation of Vanilloid Receptor Activity

2004 • 426 citations

Analgesic Therapy in Postherpetic Neuralgia: A Quantitative Systematic Review

2005 • 405 citations

Epidemiology and treatment of neuropathic pain: The UK primary care perspective

2006 • 367 citations

Health and Quality of Life Associated With Chronic Pain of Predominantly Neuropathic Origin in the Community

2007 • 302 citations

Respective potencies of Botox and Dysport: a double blind, randomised, crossover study in cervical dystonia.

2002 • 264 citations

Mechanisms of central neuropathic pain: a combined psychophysical and fMRI study in syringomyelia

2006 • 251 citations

CHRONIC HYPERALGESIA AND SKIN WARMING CAUSED BY SENSITIZED C NOCICEPTORS

1989 • 250 citations

Capsaicin-stimulated release of substance P from cultured dorsal root ganglion neurons: involvement of two distinct mechanisms

2000 • 241 citations

Presynaptic Effects of Botulinum Toxin Type A on the Neuronally Evoked Response of Albino and Pigmented Rabbit Iris Sphincter and Dilator Muscles

2000 • 214 citations

Systemic lidocaine in pain due to peripheral nerve injury and predictors of response

2004 • 183 citations

Neurobiological basis for the use of botulinum toxin in pain therapy

2004 • 172 citations

A Focused Review on the Use of Botulinum Toxins for Neuropathic Pain

2002 • 167 citations

The effects of Botulinum Toxin type A on capsaicin-evoked pain, flare, and secondary hyperalgesia in an experimental human model of trigeminal sensitization

2006 • 162 citations

Capsaicin evoked pain and allodynia in post-herpetic neuralgia

2000 • 153 citations

Mechanisms of pain in peripheral neuropathy

1999 • 143 citations

Botulinum toxin A and the cutaneous nociception in humans: A prospective, double-blind, placebo-controlled, randomized study

2002 • 124 citations

A randomized, double-blind, placebo-controlled trial of a glycine antagonist in neuropathic pain

2002 • 116 citations

A randomized, double-blind, placebo controlled study on analgesic effects of botulinum toxin A

2003 • 100 citations

Anti-allodynic efficacy of botulinum neurotoxin A in a model of neuropathic pain

2007 • 97 citations

Botulinum toxin type A in experimental neuropathic pain

2005 • 91 citations

The effects of botulinum toxin A on mechanical and cold allodynia in a rat model of neuropathic pain

2006 • 86 citations

Botulinum Toxin A reduces neurogenic flare but has almost no effect on pain and hyperalgesia in human skin

2003 • 85 citations

Botulinum Toxin type A reduces capsaicin-evoked pain and neurogenic vasodilatation in human skin

2006 • 82 citations

Botulinum neurotoxins and formalin-induced pain: Central vs. peripheral effects in mice

2006 • 79 citations

Understanding Neuropathic Pain

2005 • 75 citations

Botulinum Toxin A Relieved Neuropathic Pain in a Case of Post-Herpetic Neuralgia

2006 • 74 citations

Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study

2007 • 73 citations

Clinical value of botulinum toxin in neurological indications

2006 • 65 citations

A Lack of Antinociceptive or Antiinflammatory Effect of Botulinum Toxin A in an Inflammatory Human Pain Model

2006 • 64 citations

Botulinum Toxin A Improved Burning Pain and Allodynia in Two Patients With Spinal Cord Pathology

2003 • 61 citations

Les effets de la toxine botulique a sur ľallodynie mécanique et ľallodynie au froid chez un modèle de douleur neuropathique chez le rat

2006 • 55 citations

Botulinum toxin A does not alter capsaicin-induced pain perception in human skin

2007 • 35 citations

Upregulation of calcitonin gene-related peptide at mouse motor nerve terminals poisoned with botulinum type-A toxin

1996 • 25 citations

Chapter 3 Nociceptors: neurogenic inflammation

2006 • 12 citations